News Briefs: Supreme Court Declines PBM Fiduciary Responsibility Case

The U.S. Supreme Court declined on June 27 to hear a case that could have saddled PBMs with a fiduciary responsibility to a clients under ERISA. The case, a class action lawsuit titled John Doe v. Express Scripts, considered whether PBMs have a fiduciary duty to lower drug prices for clients, which is not the standard required by existing law or industry practice. However, some proposals currently under consideration by Congress would impose such a requirement, which could end practices such as spread pricing.

© 2025 MMIT
AIS Health Staff

AIS Health Staff

Related Posts

September 26

News Briefs: Sanders Touts PBM Promise in Pushing for Wegovy, Ozempic Price Cut

READ MORE
republican-and-democratic-party
September 26

Would Red or Blue Election Wins Be Better for PBMs? It’s a Tossup

READ MORE
pharmacist
September 26

Satisfaction With PBM Industry Dips to Record Low in 2024

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today